Molecular cooperation between HIF-1α and c-Jun (c-Jun proto-oncogene) was described in NSCLC tumours harbouring an activating mutation of EGFR, resulting in both primary and acquired resistance to EGFR-TKI [128]. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.